Pegfilgrastim for Stem Cell Mobilization in Children (Meg-5)

Summary

Hypothesis : pegfilgrastim at 200 µg/kg between 12 and 18 days after previous chemotherapy provides an efficient stem cell mobilization in children with malignancies Design: phase 2 study. Judgment criterion: percentage of children achieving at least 5x10e6 CD34 cells with a standard apheresis (less than 3 blood volume processed

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications